Skip to content

INC

Incanthera plc

Access


ISIN

GB00BGL7YW15

Bid

6.20

Mid

6.30

Ask

6.40

Key Information

Price Change
0.00%
Year High
6.55
Year Low
6.30
Last Trade
7 Nov 23
Market Cap
£4.90M
Par
0.02
Bid
6.20
Mid Price
6.30
Ask
6.40
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
77.82M
Sector
Healthcare

Prices in GBX except for Market Cap in GBP

About Incanthera plc

The Company is a specialist oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading academic institutions. The Company’s current lead product and focus is Sol, a potentially innovative topical product for the treatment of solar keratosis and the prevention of skin cancers. This has achieved proof of concept and is currently being prepared for licensing to a commercial partner within 12-18 months. The Company originated from the Institute of Cancer Therapeutics – University of Bradford and, in addition to Sol, has acquired and developed a portfolio of specific cancer-targeting therapeutics through a pipeline agreement with the Institute of Cancer Therapeutics and other corporate acquisitions. Incanthera’s strategy is to develop each candidate in the portfolio from initial acquisition or discovery to securing its future through commercially valuable partnerships at the earliest opportunity in its development pathway.<p>

Incanthera plcAccess

Latest Trades

DateVolumePrice (GBX)Value (GBP)

07 Nov 23

11:47

36,3604.501,636.20

02 Nov 23

09:56

188,5636.2111,709.76

02 Nov 23

09:55

188,5636.2011,690.91

11 Oct 23

16:29

13,1676.20816.35

11 Oct 23

12:45

71,0006.254,437.50
View all trades

Latest Announcements & Notices

DateTitle

08 Nov 23

13:20

Incanthera PLC - Result of AGM

03 Oct 23

07:48

Incanthera PLC - Notice of AGM and Posting of Accounts

02 Oct 23

07:00

Incanthera PLC - Final Results

21 Aug 23

07:00

Incanthera PLC - Warrant Extension

-
View all announcements

Address

Registered Address

76 King Street, Manchester, M2 4NH, United Kingdom

Email

suzanne.brocks@incanthera.com

Phone

+44 (0) 161 817 5005

Contacts

Corporate Adviser

Cairn Financial Advisers LLP., 9th Floor, 107 Cheapside, London, EC2V 6DN, United Kingdom

Registrar

Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal